CA1068698A - Process for preparing substituted aminoquinazoline derivatives and intermediates therefor - Google Patents

Process for preparing substituted aminoquinazoline derivatives and intermediates therefor

Info

Publication number
CA1068698A
CA1068698A CA278,728A CA278728A CA1068698A CA 1068698 A CA1068698 A CA 1068698A CA 278728 A CA278728 A CA 278728A CA 1068698 A CA1068698 A CA 1068698A
Authority
CA
Canada
Prior art keywords
formula
process according
reaction
carbon atoms
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA278,728A
Other languages
French (fr)
Inventor
Philip D. Hammen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc.
Philip D. Hammen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., Philip D. Hammen filed Critical Pfizer Inc.
Application granted granted Critical
Publication of CA1068698A publication Critical patent/CA1068698A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

ABSTRACT OF THE DISCLOSURE
2-(4-Substituted piperazin-1-yl)-4-amino-6,7-dimethoxy-quinazolines and 2-(4-substituted piperazin-1-yl)-4-amino-6,7,8-trimethoxyquinazolines are produced by reacting certain 2-chloro (or bromo)-4-(substituted amino)quinazolines with the appropriate 1-substituted piperazine to obtain the de-sired compounds directly or a 2-(4-substituted piperazin-1-yl)-4-(substituted amino)quinazoline; in the latter case the substitutent on the 4-amino group of the quinazoline is selectively removed to provide the desired compounds. The products are known hypotensive agents.

Description

.:

6~
~. ---.. .
This invention relates to a novel process for prepar ing substituted aminoquina~oline derivatives and intermediates thereforO The final products produced by the process of the invention are known chemical compounds, valuable in the ar~ by virtue of their abillty to lower blood pressure in hypertensive mammals. More specifically, these hypotensive compounds are certain 2-(4-substituted piperazin-1-yl)-4~amino-6,7-dimethoxy-quinazolines and 2-l4 substituted piperazin-1-yll-4-amino-6t7,8-trimethoxyquinazolines, which are disolosed in United State~
Patent Speci~ications No. 3,511,836 and 3,669,968. The inven-tion also relates to certain 2-halo-6,7-dimethoxy-4~substituted ~ -amino~quinazolines; 2-halo-6,7,8-trimethoxy-4-(substituted amino)-quinazolines and the corresponding compounds in which the 2-halo substituent is replaced by certain 4- ubstituted piperazinyl group~, which are novel intermediates.
~, .
United States Patent Specification No. 3,511,836 dis-closes several processes or the preparation o 2-¢4-substituted : ., .
piperazin-l-yll-4-amino-6,7-dimethoxyquinazolines. For example, by the reaotion of 2-ahloro-4-amlno-6,7-dimethoxyquinazoline with the appropriate l-substituted piperazine, by reaction o$ a
2-~4-substituted piperazin-1-yll4-chloro-6,7-dimethoxyquinazoline with ammonia or by alkylation, alkanoylation, aroylation or alkoxylation o 2-~1-piperazlnyl~-4-amino-6,7-dimethoxyquinazol-ine. United States Patent Specification No. 3,669,968 discloses the preparation of 2-~4-sub~tituted piperazin-1-yl)-4-amino- ;

-,, ~', , ' ' ' , ' ' ' o~, ~6~6~
6,7~8-trimethoxyquinazolines by the reaction of 2-chloro-4-amino-6~7l8-trimethoxy~uinazoline with the appropriate 1-9ub-stituted piperazine.
United States Patent Specification No. 3,935,213 discloses the preparation of 2-l4-substituted piperazin-1-yl)4- -~
amino-6,7-dimethoxyquinazolines and ~he corresponding 6,7,8-trimethoxyquinazolines by proaesses which comprise eithero (1) reaction of the appropriate 4,5-dimethoxy substituted or
3,4,5-tximethoxy-substituted 2-aminobenzonitrile with certain 1,4-disubsti~uted piperazines; or ~2~ reaction of the appropriate
4,5-dimethoxy or 3,4,5-trimethoxy substituted 2-aminobenzamidine with the same 1,4-disubstituted piperazines.
Compounds of the formulae:
CH30 N Cl CH30 N
~ ~ and ~ ~ N N~
CH30 ~ CH30 ~

NHCH2C6H5 NHCH2C6H5 ~-where Y is hydrogen, alkyl having from 1 to 5 carbon atoms, hydroxyalkyl having from 2 to 5 carbon atoms, alkanoyl having 2 to 7 carbon atoms, allyl propargyl, 2-methallyl, phenyl, benzyl, benzoyl, chlorobenzoyl, bromobenzoyl, trifluoromethyl, methoxyphenyl, methylphenyl, methylbenzoyl, tri1uoromethyl-benzoyl, furoyl, benzofuroyl, thenoyl, pyridinecarbonyl, 3,4,5-trimethoxybenzoyl, carboxylic acid alkyl ester where alkyl hasfrom 1 to 6 carbon atoms and carboxylic acid alkenyl ester where alkenyl has from 3 to 6 carbon atoms, are disclosed in United State~ Patent Specification No. 3,511,836. However, other intermediates, useful in the proces3 o the present invention, ~:.
are novel compound~.
In accordance with the present invention there i8 pro--- .. , '' . , :
~ . ., ~ ,. . . .
" , . , . . - . , :: , .
- : .
' ~ 6~369~3 vided a process for the preparation o~ a compound having the formu~a~
IRl CH30~ ~ y ~ ;

CH30 ~ ... I

which comprises reacting one mole o a first reactant having the . -~

formula: ~

Rl ;- : . :
CH30 ~ N q / X

CH30 ~ .

N
/ \ ... II : .

with from one to two moles of a second reactant having the -.;.
: . .
formula:
. .
~~'\ , H~ ~-R2 /
..III

in a reaction-inert organic solvent at a temperature from 50 to 200C.; wherein Rl is hydrogen or methoxy; R2 is alkenyl having from three to five carbon atoms, benzoyl, furoyl, thienyl-carbonyl, alkoxycarbonyl having from two to five aarbon atoms, alkenyloxycarbonyl having four or five carbon atoms or ¢2-hydr- ~ ~ ~
oxyalkoxy)carbonyl having four or five oarbon atomis; X is :. -chlorine or bromine; R3 is hydrogen and R4 is -C~2C6H4R5, --COOCH2C6H4R5, -COR6, -COCF3, -CHO or -COOR6, or R3 and R4 together with the nitrogen atom to which they are attaahed orm a ayclic imido group, preferably a phthalimido, maleimido or ; ~ , ", , , ": : :,, ,,, " ;, " ~ ,, ,", ,,", ",, "", , , ;" , , , , ,, , , "

r~ ` 10686~3 succinimido group; R5 is hydrogen, ahlorine, bromine, methyl, methoxy or nitro; and R6 is alkyl having from one to four carbon atoms or -C6H4R5.
An especially preferred range of temperature is from 80 to 130C.
When the above process is carried out with reactants ~ and ~ wherein R2 is benzoyl, furoyl, thienylcarbonyl, alkoxycarbonyl having from two to five carbon atoms or (2-hydr-oxyalkoxy)carbonyl having four or five carbon atoms; R3 is hydrogen and R4 is CH2C6H4R5 it is preferred to react equi-molaramounts of said reactants. An intermediate compound having the formula~
Rl ~ . .
CH30~N ~I-R~

~N
R3 R4 . . o IV
wherein Rl, R2, R3 and R4 are as defined above, is obtained and this intermediate compound is further reacted by catalytic hydro-genolysis to form the flnal product of formula (I). An ~ especially preferred aatalyst for the hydrogenolysis is palIadium.
: When the process of the invention is carried out with a first reactant of formula (II) wherein R3 and R4 together with the nitrogen atom to which they are attached form a phthalimido, maleimido or succinimido group, it is also preferred to employ an equimolar amount of each reaatant to form an intermediate of formula (IV~. In which case, the said intermediate is further reacted at a temperature from 0 to 100C. to form the inal 25 product o formula ~ ta~ by hydrolysis, or ~) by reaction
-5-,:

, ' , ,, " , ~'. ' .,.,, ' ' .
. ' - . ' ' ' ' ' ' , ,' ''' ,' " ' ''' ~ ~, '' ,, "
'' ' , ' ', -~ ~L068698 with an equimolar amount of hydraæine in the presence of a re- :
action inert organic ~olvent.
... ~.
An especially preferred temperature for further re- ~ :
acting the intermediate of formula ¢IV) by hydrolysis or with ~ ~
S hydrazine is from 20 to 50C. . : : :
When hydrolysis is employed it is preferred that it be carried out in the presence of hydrochloric, hydrobromic, sulfuric or phosphoric acid.
When the process of the inv2ntion is carried ou~ with :
a compound of formula (II) wherein R3 is hydrogen and R4 is .
COOCH2C6H4R5, -COR6, COCF3, -CHO or -COOR6 wherein R5 and R6 : are as previously defined, the desired compound of formula ~I), or the hydrochloride or hydrobromide addition salt thereof, is :
directly provided In the latter case it is preferred to react one mole of the first reactant of formula ~II) with two moles of the seaGnd reactant of formula ~III).
Whereas the process of the present invention is u~eful for the preparation of the said, known, ~ypotensive agents of formula I, it is especially useful for the preparation of two ::
: 20 particularly valuable compounds of formula I, namely, 2-[4-12- .
furoyl~piperazin-l~yl~-4-amino-6,7-dimethoxyquinazoline and 2-[4-~2-hydroxy-2-methylprop-1-yloxyaarbonyl~-piperazin-1-yl]-4-amino-6,7,8-~rimethoxyquinazoline, ~nown in the art as pra~o~in and trimazo~in. 2-~4- ~-Methylprop-2-enyloxycarbonyl)-piperazin-1-yl~-4-amino-6,7,8 trimethoxyquinazoline i~ a vaIu-able starting material for the production of trimazosin ¢United States Patent No. 3,669,968). Prazosin and trimazosin have - :
recently been reported to have therapeutia utility in man ~Cohon, ~ , 10, 408 ~1970~; De Guia, et al., ; 30 ~ , 15, 339 [1973]).
-6- . : ~.
;~

., .: . , ., . . ,, ~
. . ., , . , , , , , , ,, . - , , , .. : . :
.. , , . . , , ~ , , .

-- ~06~369~3 The invention also provides novel and useful inter-mediate compounds of formula ~V)~
Rl ;

R30 40 ..OV
: ~ wherein X and Rl are as previously defined, R30 is hydrogen and R40 is -COOCH2C6H4R5, -COR6, -COCF3, -CHO or -COOR6 or R30 and R40 together with the nitrogen atom to which they are attached form a:cvclic imido group, preferably a phthalimido, maleimido or succinimido group; and R5 and R6 are as defined above.
The invention further provides useful lntermediate : 10 compounds of formula ¢VI) l A
C 30~N~i-R

R31 R41 ...VI
wherein Rl and R2 are as previously defined and R31 and R41 together with the nitrogen atom to which they are attached form ~ a cy¢lic imide group, preferably a phthalimido, maleimido or succinimido group.
~he present invention provides a proae~s for the preparation o a compound of the formula ~I~ above, or a hydro-chloride or hydrobromide acid addition salt thereof, by reacting a compound of the formula (II) with a compound of formula III.
In certain ca~es, described in detail below, an
-7-:: . '';, .' ' , ' . ' ' i ' " '' ' ' :

: , f ,, ' '.',, .,'. , ~ ~ , I
,', ,'' ' ' 06~36~8 intermediate compound of formula ~IV~, or acid addition salt thereof, is initially obtained which is further reacted to obtain a compound of formula ~I) The reaction of compounds of the formulae ~I and III~ is carried out in the presence of an appropriate reaction inert oxganic solvent. An appropriate sol~ent is one which will serve to substantially dissolve the reactants, and will not adversely interact with reactants or products of the reaction. Examples of such solvents are alkanols such as isopropanol, butanol, isobutanol, isoamyl alcohol, 2-methyl-2-pentanol and 3,3-dimethyl-1-butanol; glycols such as ethylene glycol and diethylene glycol; glycol ethers such as ethyleneglycol monomethyl ether, diethylene glycol monoethyl ether, 1,2-dimethoxyethane, and diethylene glycol dimethyl ether;
tertiary amides such as N,N-dimethylformamide~ N,N-diethylacet-amide and N-methylpyrrolidone; dimethylsulfoxide and pyridine.
While the reaction may be carried out over a wide range of temperature, a temperature in the range of 50 to 200C. i pre-ferredr An especially preferred range of temperature is from 80 to 130C. The time required for the process to reach sub-stantial completion varies according to several factors, suchas, for example, the reaction temperature, reactivity of the partiaular starting materials employed and the concentration o reactants. At lower temperatures longer reaction times are ,!,1' '~
needed, while at higher temperatures the reaction is completed in a shorter time~ A reaction time of from 15 minutes to 50 hours is generally suficient~
In certain cases the reaction of a compound of formula ~II) with a compound of formula ~III) forms an intermediate com-pound of formula ~V) which is then urther reacted to obtain the desired compound of formula (I). Thus, the process of the
-8-- . . . .
,, . :, 6~3691!3 invention may be carried out by either of two methods, designat-ed as Method A and Method B, as shown in the following reaction scheme~ -CH30 ~ X CH3O I N A--R~
~ ~ ~ ~ ~1 A Methsd A ` ~ ~ ~ \

CH30 ~ ~ 3 / N ~III) / N

OV) C~3o ~ ~ N ~ -~

CH30 ~ ::

(I~
The compounds o formulae ~II) and ~III) employed as reactants in the process of the invention are those wherein X
is chlorine or bromine and particularly preferred are compounds wherein X is chlorine; Rl is hydrogen or methoxy; R~ is alkenyl having from three .to five carbon atoms, benzoyl, furoyl, thienyl-carbonyl, alkoxycarbonyl having ~rom two to five carbon atoms, alkenoxycarbonyl having four or five aarbon atoms or (2-hydroxy-alkoxy~aarbonyl having four or five carbon atoms~ When taken separately, R3 is hydrogen and R4 is -CH2C6H4R5, -COOCH2C6H4R5, -COR6, -COCF3, -CHO or -COOR6 and when taken together with the nitrogen atom to which they are attached R3 and R4 form a cyclic imido group. Examples of such cyclic imido groups are _g_ .. . . .

; .
, . , . .. , ,,, - . ; , . :-~' .
, .
:'.

-`` 106~6~
phthalimido, succinimido, maleimido, glutarimido, and imido groups derived from other cyclic diaarboxylic acid anhydrides such as diglycolic, thioglycolic, cyclohexane-1,2-dicarboxylic, 4-bromophthalic, 3-nitrophthalic and methylmaleic acid anhydride.
Preferred cyclic imido groups are phthalimido, succinimido and maleimidoO R5 is hydrogen~ chlorine, bromine, methyl, methoxy or nitro; and R6 is alkyl having from one to four carbon atoms or -C6H4R5.
When the process of the invention is carried out accord-ing to Method A, as depicted in the above reaction scheme, it is preferred to employ compounds of the formula (II) wherein X is chlorine or bromine; Rl is hydrogen or methoxy, and R3 is hydro-gen and R4 is -CH2C6H4R5 wherein R5 is as previously defined, or R3 and R4, together with the nitrogen atom to which they are attached, form a phthalimido, maleimido or succinimido group.
Such compounds of formula ~II) react with the above described , compounds of formula ~II) to obtain intermediates of formula : --~IV), a hydrochloride or hydrobromide salt thereof~ When such compounds of formula ~IV) are desired it is preferred to carry out the reaction employing approximately equimolar amounts of :
the reactants for reasons of economy and efficienay. However, ;
this is not essential to the suacess of the reaction, and an excess of either reactant may be presen O The intermediate com-pound of formula ~IV~ conveniently may be isolated in the form ~5 of the hydrochloride salt or hydrobromide salt each o~ which is ordinarily insoluble in khe reaction solvent and thus may be obtained merely by filtration and washing. Alternatively, the above mentioned salts can be treated during workup of the reac-tion mixture with an alkaline reagent such as, for example, sodium hydroxide, potassium hydroxide, po~assium carbonate, or . .

, ' ':'. ' . . : ; , ' ; -,. , , . ~.,.
. .

106~6g~
sodium methoxide, ~ollowed by e~traction of the free base into a water immiscible solvent such as, for example, chloroform, dichloromethane or benzene; and evaporation to dryness. When desired, either the compound of formula (IV) or the salt there-o~ may be further puri~ied by standard methods such as crystal-lization or column chromatographyO However, they are often of sufficient purity for further reaction to form compounds of formula ~I~ without such further purificationO
As mentioned above, the compound of formula (IV) or 10 the hydrohalide salt thereof is further reacted to remove the 4-amino substituents, R3 and R4, to obtain the desired compound of formula ~. When employing a compound of formula ~IV) wherein R3 is hydrogen and R4 is a benzyl group, -CH2C6H4R5, the pre~erred values of R2 are benzoyl, furoyl, thienylcarbonyl, 15 alkoxycarbonyl having from two to five carbon atoms and ~2-hydroxyalkoxy)carbonyl having four or five carbon atomsO It is preferred to remove the benzyl group by catalytic hydrogenolysis.
The term "catalytic hydrogenolysis" as used herein i6 well underskood by those skilled in the art of hydrogenation, and is 20 illustrated in the Examples appearing hereinafter.
The catalytic hydrogenolysis may be carried out by a variety of procedures well known in the art for this type of transformation, such as tho~e discussed by Augustine in "Catalytic Hydrogenation", Marcel Dekker, Inc., New York, 1965, 25 ppO 139 to 142. A particularly convenient procedure comprises contacting the compound o~ ~ormula (IV), wherein R3 i9 hydrogen and R4 is -CH2C6H4R5, with hydrogen, in a reaction inert solvent medium and in the presence of a suitable catalyst at an appro-pria~e temperature and pressure until hydrogenolysis is complete.
30 Thereafter the desired product o~ formula tI) may be recovered ,,, .,,...................................... "' ' ' .

~` ~068698 by conventional methods involving catalyst removal and recovery of the product from the solvent mediumD
As used herein "reaction inert solvent medium" refers to any medium which is a solvent or suitable suspending agent for the reactant~ is stable under the hydrogenolysis conditions and does not interfere with the effectiveness o the catalyst or interact with the reactant or product Polar organic solvents are generally suitable and include the lower alkanols such as methanol, ~thanol and butanol, cyclic and straight chain water soluble ethers such as dioxane~ tetrahydrofuran, diethylene glycol monomethylether, 2-ethoxyethanol, the lower alkanoic ;~
acids such as acetic acid or propionic acid~ aqueous media in-cluding the foregoing solvents, and dilute aqueous hydrochloric -acid. These solvents and others are conventional in known hydro-genation techniques and hence are not criticalO --~
The temperature is no more critical than it is in other known hydrogenolysis reactions Thus, a temperature of from 0 to 100Co may be employed with good results. The preferred range of temperature, however, is from 10 to 60C~
and room temperature is especially pre~erred for reasons of -convenience O At temperatures below 0C~ the reaction is in-ordinately slow whereas at temperatures above 100C~, decomposi-tion o the starting material may occur. The higher the tempera-ture, the faster the reaction rate~ However, the reaction, ordinarily~ is complete in 1 to 24 hoursO
Suitable catalysts for obtaining the desired products of formula ~I3 in the hydrogenolysis reaction are platinum, palladium, rhenium, rhodium and ruthenium, either o the supported or non-supported type, as well as catalytic compound thereof such as the oxides or chlorides1 Examples of suitable . .

~ ' ' ' ' " , . " ' ' ,. , ' , . ' ' ' ' ' ~ ' , ' ' ' '; ~
''.' ,''. ".' '. "', ' "~' ' " '','' """"'"".,, .' .'''1,.'''. " , ,, "' . ',,',, ' ' . '," ", ''' " ' '' ' ,.. ..
' . , ', ., ' ,' '' "' '''','.".' ' .' ' '"','' "' ~ ' ~.",, ' ''',' "."',"", 69~3 catalyst supports are carbon, silica and barium sulfate.
Especially preferred as catalyst is palladium for reasons of economy and e~ficienc~
The catalyst is ordinarily employed in an amount of ``
rom 10% to 100~ by ~eight based o~ the said starting compound of ormula ~IV~o The pressure employed during hydrogenolysis is not critical, for example, satisfactory results may be obtained at pressures var~ing from ambient pressure to 100 atmospheres.
When employing the compounds of formula ~IV) wherein R3 and R4 together with the nitrogen atom to which they are attached form one of the above mentioned cyclic imido groups, : ~he said aompounds ~V) are further reacted by hydrolysis or with hydrazine to provide the desired products of formula tI).
: lS The said hydrolysis may be carried out under alkaline conditions in the presence of, for example, sodium hydroxide or potassium hydroxide, or under acidic conditions employing a suitable acid.
Examples of such suitable acids are hydrochloric, hydrobromic, :
sulfuric, phosphoric, hydroiodi~, dichloroacetic and trifluoro-ace~ic acidsO For hydrolysis of the preferred cyclic imido compounds of formula ~IV) it has been found to be particularly convenient and efficient to employ hvdrochloric, hydrobromic, suluric or phosphoria acid It is preferred to carry out the hydrolysis with one of these acids at a temperature in the range of 0 to lOO~C , a particularly preerred range of tempera-ture for such hydrolysis is from 20 to 50C~ At temperatures below 0C., ~he hydrolysis rate is inordinately slow, At temperatures above lOO~Co ~ excessive amounts o~ decompositio~ .
products are generated~
The mole ratio of the above acids to the compound of ': '` .

. , . ~:,. .,,. .,. , . , , . , . ; ~.. :: .
.. : .. - .: . ., ,: ., ., ... , : ,:, . , .. ,, . : . ... .
.: ,., : : .. , , .. . : ,'~ ' ` i .' : , ': ; ' : : ` ~ ' ' ' ~ 36~69t3 formula ~IV) may vary over a wide range, thus mole ratios of from 1:1 to 200:1 may be employed with satisfactory results.
The time required to reach substantial completion of the hydro-lysis will vary according to the reaction temperature, and ordinarily when carried out at 100C. only a few minutes is ;
sufficient and when carried out at 0C. up to 24 hours may be required to reach completion~ The hydrolysis may be carried out in an aqueous medium or an aqueous-organic medium employing a water immiscible organic solvent su~h as, for example, chloro-form, methylene dichloride, benzene, or toluene. Upon comple-tion of the hydrolysis, which may be determined readily by thin-layer chromatography on silica gel employing, for example, a 95 5 ethyl acetate/diethylamine solvent system, the desired product of formula ~Ii may be isolated as a salt of the acid used in the hydrolysis, employing methods well known in the art.
However, it is ordinarily more conuenient to adjust the reaction mixture to an alk`aline pH by addition of, for example, sodium hydroxide, potassium hydroxide or sodium carbonate, followed by extraction o the compound of formula ~I) as the free base, employing, for example, one of the above mentioned organic solvents optionally employed in the hydroly6is. The product is then readily isolated by evapo~ation.
Alternatively, as mention~d above, the intermediate of ~ormula ~IV) wherein R3 and R4 together with the nitrogen atom to which they are attached form one of the cyclic imido group~, may be urther reacted with hydrazine to provide the final product o formula ¢I~. The use of hydrazine to remove the phthaloyl group from phthalimido acids or the corresponding lower alkyl esters is known in the art, see, for example, ~30 Boissannas, A ~ , 3, 179-133 ~1963) and . , , . ~ - , ,. - .. " , . -:, ........... ,; .... ,.. : : :, :, ., - , :. , ,: ~: :, ~ 68698 Sheehan et al., Jour. Amer. Chem. Soc., 76, 6329 (1954). It __ _ has now been found that the above intermediates of formula (IV) containing one of the previously mentioned cyclic imido groups and especially those containing the phthalimido, maleimido or sucoinimido group also react to provide the desired products of formula ~I~. The reaction is carried out in the presence of a reaction inert organic solvent. Examples of organic solvents which may be employed for this reaction are the lower alkanols such as ethanol, propanol, isopropanol, butanol, and isoamyl alcohol; N,N-dime~hylformamide, N,N-dimethylacetamide~ dimethyl-sulfoxide, diethyleneglycol dimethylether and diethyleneglycol monoethylether.
The hydrazine employed may be substantially pure hydrazine or a derivative such as hydra~ine hydrate, hydrazine hydrochloride or hydrazine sulfate. When the acid addition salts are employed the hydrazine is generated ln situ by addition of a suitable base to neutralize the acid. Examples of such suitable bases are sodium methoxide, potassium carbonate, triethylamine, triethanolamine, and sodium hydroxide. While a molar excess of hydrazine up to five moles per mole of intermediate ~IV) may be successfully emploved in this reaction, it is preferred to employ an equimolar amount of hydrazine to minimize possible side re-actions and for reasons of economy. It is preferred to carry out the reaction with hydrazine at temperatures from 0 to 100C.
A particulaxly preferred range of temperature is from 20 to 50C. At temperatures above 100C. unwanted side reactions occur, while at temperatures below 0C. the reaction rate is inordinately slow.
The time re~uired to reach substantial completion of reaction will, of cour3e, vary with the temperature and the :

:, ~, ;

.. , . : : . , . . . . , ~ : . . .

`~ ~L06~365~
prec~se nature of the reactants and solvent~ Ordinarily, how-ever, the reaction with hy~razine to form the final product of formula ~I) will be suhstantially complete in from 1 to 48 hours. ~he reactlon of hydrazine with the above cyclic imido compounds also forms a cyclic hydrazide by~product, such as, for example, phthaloylhydrazide in the case of the phthalimido intermediates. ~he reaction mixture may be freed from the by-product cyclic hydrazide and the desired product of formula ~
may be isolated by methods well known in the art such as, for ~-example, evaporation ln vacuo to dryness, trituration of the residue with dilute strong mineral acid such as hydrochloric, or sulfuric acid in which the cyclic hydrazide is usually only sparingly soluble, filtering and adjusting the filtrate to an alkaline pH~ whereupon the desired product is isolated by extrac-tion or filtration.
When a compound of the formula (II) wherein Rl is hydrogen or methyl, R3 is hydrogen and R4 is -COOCH2C6H4R5, -COR6, -COCF3, ~CHO or -COOR6 wherein R5 and R6 are as previous-ly defined is reacted with a l-substituted piperazine of formula (III3 in the process of the invention, the reaction proceeds directly to provide the desired compound of formula ~I) as indicated by Method B in the above reaction scheme. Thus, with such a compound of formula ~II), the 1-subs~ituted piperazine ~ reacts at both the 2-position of the quinazoline (II) to displace the halogen atom, X, (X = Cl or Br) and to remove the R4 group when R3 i~ hydrogen and R4 is one of the above carbonyl containing groups, to obtain a compound of formula ~I) in a single step.
While Method B may be carried out conveniently employ- ~
iny molar ratios of compound ~II) to compound (III) from 1:1 to -.. , . , . : , . , .. " . . .. . .

, ' :'', ' ' "' ' ' . ,,' ~' , ' ' ~ .' : .
"
- , '.' '' . ' : ' , .:
:" ,: ,: , ......... . ..
.. .. . . .

-~-` lOG8698 3:1 or higher, it is preferred to react the compound o~ ~ormula ~ with the compound of formula (III) in a molar ratio of 2:1 for reasons of efficiency and economy.
When the process of the reaction is carried out according to Method B, the desired produc~ of formula ~I) i9 readily isolated by standard methods either in the form of the hydrochloride salt ~when X is chlorine~, the hydrobromide salt (.when X is bromine) or as the free baseO For example, when a compound of the formula (II) wherein X is the especially pre-ferred chlo~ine is reacted with two moles of a compound o formula ~III), the hydrochloride salt of compound (I) is rdinarily obtained merely by filtration of th~ reaction mix-ture an~ washing the product~ When the free base of the product of formula ~I) is de~ired, the reaction mixture, upon completion of the reaction, is treated with an excess of an aqueous solution o~ a strongly alkaline reagent such as sodium hydroxide, potassium hydroxide or sodium carbonate and the free base extracted with a water immiscible solvent such as chloroform, methylene chloride, 1,2-dichloroethane, or benzeneO The product may then be obtain-ed, for example, by evaporation of solvent and further purified if desiredO - :
While intermediates o the formula ~II) wherein Rl is hydrogen; R3 is hydrogen and R4 is benzyl are disalosed in .:
United States Patent Specification NoO 3,511,836 and inter-mediates of ormula ~IV~. having the same values or Rl, R3 and .;~ . :R4 and R2 is as previously described are claimed therein, certai~ ; ;
of the remaining compounds o ormulae (II) and (IV) are novel ~ .:
compound~D The nov~l intermediates falling within formula are those of the formula ~V) as defined hereinabove. .~
-~ 30 The novel intermediates falling within.formula ~IV) ~ ;
-17- : .

, ,. . ., j .. . . . . . .

::" ,., '~' ", '. ., ' , ,. ' ~,. , ,'"' . .' . ' '' . ' `' .: . ' ' " ' " ' ' '"' ' ' ' ' ' ' ', '''' ', ' ', . ''', ."" ,' ' ,', '' .'" ' "," '', , ~ ' ""'"" " ""' "' ' ' ,' '' ''. ' ' " ' ' '. ;. ~ ' '' ' . . ~ ' ' ,'", ',"''" ,, '''' ''''','' ", ''' '"' ' '. " "" ," '' "', ', "' ' ,' " ~' "' " ' '' ~196~36~1 ,` ,~
are those of the ormula ~VI) as defined hereinabove.
The novel intermediate~ of formulae (V) and ~VI) are patentably distinc-t from the prior art compounds of formula (II) and ~IV) in view of the above mentioned differences in the methods by which the R3 and R4 groups are removed to provide the desired compounds of formula ~I~. That is, the prior art compounds of formula ~I) wherein R3 is hydrogen and R4 is benzyl react with the compounds of formula ~ to provide the corresponding known compounds of formula ~IV~ where R3 is hydrogen and R4 is benzyl.
In order to remove the benzyl group, the compound of formula (IV) is subjected to hydrogenolysis as discussed above. By contrast, the novel compounds of formula (V) wherein R30 is hydrogen and R40 is -COOCH~C6H4R5, -COR6, -COCF3, CHO or -COOR6 and R5 and R6 are as deflned above, react with compounds of formula ~III) to provide the desired products of formula ~I), directly. The com-pounds of formula ~V) wherein R30 and R40 together with the nitrogen atom to which they are attached form a phthalimido, maleimido or succinimido group react with the compounds of formula ~III) to provide the novel intermediates of formula ~VI) which, in turn, provide the desired compounds of formula ~I) by hydrol~sis or reaction with hydrazine as described previously.
The above described intermediates of formulae ~II) and ~V) are prepared from the appropriate 2,4-dihalo-6,7-dimethoxy-quinazolines or 2,4-dihalo-6~7,8-trimethoxyquina~olines, where halo is chloro or bromo. Preparation of said dihalo compounds are previou~ly described in United States Patent Specification~
No. 3,511,836, and 3,669,963 and by Curd et al., Jour. Chem.
, 777 ~1947); ibid., 1759 ~1948).
In the preparation of the novel intermediates o~
j30 formula ~V) one of the above 2~4-dihaloquinazolines is reacted .. -. . : . . . .

, S16~8 with an appropriate cyclic imide, primary amide or urethan in a xeaction inert organic solvent and in the presence o a strong base such as, for example, sodium hydride, potassium hydride, calcium hydride, sodium methoxide, potassium ethoxide, lithium butoxide or butyl lithium, under anhydrous conditions. ~fter the reaction is substantially complete, the compound of formula (V) is isolated by standard methods known in the art, for example, by quenching the reaction mixture in an excess of water or dilute acid and filtering, washing and drying to obtain said product. Quenching in dilute acid is preferred when said amide or urethan is employedO
Examples of appropriate cyalic imides are any of those previously mentioned; preferred cyclic imides are phthalimide, maleimide and succinimide. Preferred primary amides are form-amide, trifluoroacetamide and those of the formula R6CONHwhere R6 is alkyl having from one to six carbon atoms or -C~H4R5 wherein R5 is hydrogen, chlorine, bromine, methyl, methoxy or nitroO Preferred urethans are those of the formulae R5C6H4CH20CONH2, and R60CONH2 whérein R5 and R6 are as previous-. .
~ 20 ly definedO ~ ~
:. .: :.
Examples of reaction inert organic solvents which may be employed are N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, ethyl ether, tetrahydrofuran, 1,2-dimeth-oxyethane, dimethylsulfoxide, toluene and benzene. Preferred ~-~5 reaction inert organic solvent are N,N-dimethylformamide and tetrahydrofuran, -In carrying out the reaction to provide the novel intermediates of formula ¢V) the preferred strong base for reasons of economy and eficiency is sodium hydride. A mole ratio of said strong base to said 2,4-dihaloquinazoline o~ at ~L~61~698 ', ,, least 1:1 is ordlnarily employed and mole ratios of from 1:1 to 2:1 are preferred.
Whil2 the above reaction may be carried out over a wide range of temperature, a temperature in the range of from 0 to 150Co and especially f.rom 65 to 100C. is preferred.
Below 0C. the reaction is inordinately slow while at tempera-tures above 150 C ~ ~ excessive amounts of undesired by-products are obtained~ The reaction rate is faster at higher temperatures and the time required to reach completion will vary with the temperature as well as the specific nature of the reactants and solvent. Eowever, the reaction is ordinarily complete in from 2 to 24 hoursO
The following Bxamples illustrate the invention.

:, ' ' .

-20- ~-.. .

.
.
.. . . . . ..
- ' ' ~ - ' ' ' ;
- , ' . '.

. . :

~C)6136~8 `:~

.

In a 200 ml. three-necked round bottomed flask was placed 6.48 g.
(0.025 mole~ 2,4-dichloro-6,7-dimethoxyquinazoline and 104 ml. of tetrahydro-furan. The flask was heated by means of an oil bath held at 70C. To the flask was then added 2.68 g. (0.025 mole) of benzylamine and the resulting mixture heated with stirring for one hour. An additional charge of 2.68 g.
benzylamine was added and heating continued for one hour, after which another 2.68 g. of benzylamine was added. The mixture was heated for an additional ~ ~ -2 hours, then filtered while still hot to remove precipitated benzylamine hydrochloride. The filtrate was concentrated to half volume, two volumes of hexane was added and the resulting mixture was stirred slowly for thirty minutes to effect granulation. Upon filtering and drying 6.0 g. (73~) of the title compound was obtained, M.P. 190-195C. The structure was verified by means of nuclear magnetic resonance spectroscopy (NMR) and mass spectroscopy.

' " ';
.. ~ .
. ,, ,:

" ": , ., , : . , . , , ,, : . . , :. ". . - :::
.. . , . - , - - -,: - ~ .. . ::: : .,,, . : . . :

~06~698 ,. , ~X~MPI.~ 2 2-[4-(2-Furoyl)piperazin-l-yl]-4-bell~ylamino-6,7-dimethoxyquinazoline ¦ In a 200 ml., three-necked, round bottom flask fitted with therm~-5 ¦ meter, condenser and drying tube was placed 66 ml. of isoamyl alcohol and 6.0 g. (0.018 mole) of 4-ben~ylamino-2-chloro-6,7-dimethoxyquinazoline. To this was added a solution of 3.6 g. (0.020 mole) 1-(2-furoyl)piperazine in 50 ml. of isoamyl alcohol. The resulting mixture was heated at reflux (130 C) ~for 4 hours, cooled to 20 C;, filtered, washed with ethyl ether and air dried to obtain the hydrochloride salt of the title compound. This was converted to the free base by dissolvinz in 150 ml. hot methanol, addihg 1.3 g. of sodium methoxide, stirring at 50 C. for tcn minutes, cooling to 20 C., addin~
100 ml. of water, followed by extraction with two 100 ml. portions of chloro-I form. After concentration of the extracts to dryness 6.0 g. (70%) of the I . ~ :
15 ~ title compound, M.P. 220-225 C., was obtained.
~ When tnè above procedure is carried out at 80- C. for twenty four ; hours the results are substantially unchanged.
When the reaction is repeated using carbitol (diethyleneglycol ¦ momoeehyl ether) as solvent and heating at either 200 C. for 20 minutes or 20 ~ at 5~ . for 48 h~-r:, tle .itle cmmpo~ d i8 ~imilarly obtaln~d.

~ , ', , .
. ,~ , .

I ~ -22-;.:. ~ ' :
, . , - . . : . . . .
. ~ :: ' ' ' ' - ' ' ' ' ' : ' .

,",............... .... ..... ..

EXAMI~.~ 3 2-[4-(2-~uroyl)piperazin-1-yl]-4-arllino-6,7-dimethoxy-_ q~nazoline~Prazosin)~

I In a Paar bottle was placed 1.0 g. (2.1 millimoles) of 2-[4-(2-furoyl)piperazin-1-yl]-4-benzylamino-6,7-dimethoxyquinazoline and 15 ml. of -ethanol. I~ater (about 5 ml.) was added to the cloud point, then 400 mg. of palladium-on-carbon (50% wet) catalyst~ The resulting mixture was shaken in e Paar hydrogenation apparatus at SO p.s.i. for 18 hours, filtered and the ~filtrate was ~slurried with 50 ml. of chloroform and filtered a8ain. The 10 filtrate was concentrated in vacuo to 10 ml., granulated ~or 15 minutes and -filtered to obtain 450 mg. (56%) of the title compound, M.P. 263-265 C. 9 identified by thin-layer chromatography o~ a silicn gel plate (ethyl acetate/
¦ dieChylamine 95:5 solvent system) and by comparison of the infrared spectrum with that obtained on an authentic sample of prazosin. ;~

';
. , . ~-: "
! . . . . ., ' ` ' .

I :
. .~ . .
. , `~
.. , .. ~ .. .
. . . ,, , . : :'-' -23- i ' ~ ` ~(1 686~8 EXAMPLE 4 ~ .
' .
. When the procedures of Examples 1 and 2 are repeated but employing : .
........................ . ; .
the appropriately substituted benzylamine in each case in place of the benzyl-amine employed in Example 1, the followin~ compounds are similarly obtained.
. . :
. ' ': - ' ;~ 5 t : 4-N02- 2-Br-2-N02- 4-Br-. 2-Cl- 2-CH3-3-Cl- 3-CH3- : . :
10 ¦ . 4-Cl- 4-CH3-. 3-CH30- ! '~
4-CH30- ¦
~, , I ' . '' I '- ., ' I .' ' ~: I EXAMPLE 5 .I~en the procedure of Example 3 is repeated, but with any of the lS I compounds obtained in Example 4 in place of 2-[4-(2-furoy')piperazin-1-yl]-: I 4-benzylamino-6,7-dlmethoxyquinaizoline, 2-[4-(2-furoyl)piperazin-1-yl]-4-amino-. I ~,7-dlmet xyqoinazoline i~ cbtained in like manner.
I . .
~ ' . , . ' , .
' : ' ~ -24- :

', ~ ', ', '- - - . . , .
". :; . . , - , : . :
:. . .
., : ~: . .

, ,' ' ' 1(:~6l~69~ , : ~
: . ! ~ . ~ :
EX~MPLE 6 ;
2-Chloro-4 ~hthalimido-6,7=dimethoxyquinazoline To a 100 ml. three-necked, round bottomed flask fieted with thermo-meter, stirrer and drying tube ~as charged 50 ml. of N,N-dimethylformamide, -1.47 g. (0.010 mole~ phthalimide and 0.48 g. (0.010 mole) o~ 50~ w/w sodium hydride. After stirring at room temperature for thirty minutes a clear solution was obtained. To this was then added 2.59 g. (0.010 mole) of 2,4-dichloro-6,7-dimethoxyquinazoline and the resulting mixture ~as heated at 100 C. for 5 hours. The reaction mixture wa. cooied to room temperature, -150 ml. of water added and the precipitated product isolated'by filtration and dried jin vacuo to obtain 3.1 g. of thc title compound, M.P. 255 C. The I~ ~u~e~ e ~s ~ ~fle~ by NUR and = ~s s ec~ral ~ ta. Yie~d, 84X.

1, ~ I .. , I ~
.. . ' ' '' .
~' . .
, .

.:' ' ' ' "` '' ' '~'' '' . , ~ .. , ,.: . , . ... ,. . . ., , . . . . , ;. . . . . . .

1¦ iO6B698 ,~..;
, ! .
X~MPL~ 7 2~[4-(2-Furoyl)pipera~in~l-yl]~4-phthalimido~
_ 6~7-dimethoxyquinazolinc~
. ' ' , I ~ :.
To a 35 ml., one necked, round bottomed flask fitted with con~ ¦
denser and drying tube was placed 1.0 g. (0.0027 mole) 2~chloro~4~phthalimido~
6,7~dimethoxyquina~oline, lO ml. isoamyl alcohol and a solution of 0.550 g.
,~ (0.003 mole) 1~(2~furoyl)piperazine. The resulting mixture was heated at 130 C. for 4 hours, then cooled to room temperature. To the reaction mlxture , ~ 35 ml. of hexarje was added and the precipitated product collected by filtra~
tion and dried to obtain 0.70 g. (47%) of the hydrochloride salt of the title compound. The purified free base was obtained from the salt by silica gel . . .,.:
chromatography on a 2 inch x 12 inch colun~l, eluting with ethyl acetatc/
diethylamine (90:10). The purified product melted at 305 C. r ¦ When the above procedure is repeated but employing ~he indicat~ed , . -solvent in place of isoamyl alcohol and the indicated temperature and reactior ti~e, the title compound is likewise obtained. ¦
I' l i SolventReaction Reaction TemperaLure, C Time, Hours Isobutanol50~ 48 1,2-Dimethoxy~
I ethane 80 30 ¦ Diethyleneglycol monoethyl ether 200 ,, , .~, . :~' . '' '' ' . .
. . ..
., ~ ,~ , . .
~ -26- .
,. - . .'` , ' .
.
. . - ~. , - , . , , ,.. ~:~
.
,. :. . . .
,. . . . .

~::" ~(~61~6~8 ' I
XAM ~ 8 . ' , . .i :.. ' . ' ' '- ':
A solution of 95 milligrams (0.185 millimole) of 2-[4-(2-furoyl)piparazin-l-yl]-4-phthalimido-6,7-dimethoxyquinazoline in 2.0 ml. of -~ -concentrated hydrochloric acid was stirred at room temperature for two hours.
Then 4.0 ml. of chloroform was added and the mixture adjusted to pH 10 by addition of sodium carbonate solution. The chloroform layer was separated and evaporated to dryness to obtain 55 mg. (77.6X) of 2-[4-(2-furoyl)piperazin-l-yl]-4-amino-6,7-dimethoxyquinazoline, M.P. 270 C. The structure was verified by com~arison of the infrared spectrum with that of an authentic sample, and by thin-layer chromatography on silica gel using,a 95t'5 ethyl ', , ' `'. ,':'';:, -? , .

-27- .

.. : . ., ~ , ' . , ' ,' ~. :

. 106869~3 ~

EX~n~LE 9 A suspension of 5.14 g. tO.Ol mole) of 2-[4-(2-furoyl)piperazin-1-yl]-4-phthalimido-6,7-dimethoxyquinazoline in 200 ml. of isoamyl alcohol is heated to effect solution and 0.55 g. (0.011 mole) of hydrazine hydrate is added. The resulting solution is stored at 20 C. fo~ 18 hours then evapo-rated to dryness under reduced pressure. The residue is triturated with 30 ml. ~-of 0.5 N hydrochloric acid and stored at 4 C. for two hours. The solution was filtered to remove the precipitated phthalhydrazide. The filtrate is made alkaline(pl~ 10) 'with sodium hydroxide solution extracted with chloroform and the extracts concentrated to dryness to afford 2-14-(2-furoyl)piperazin-1-yl]-4-a~ino- ,7 dimethoxyqui==zoline.

.
!, ~:

.
., , . .' , '. ,'.

. , ". ..
.~'' . .
.' ' . ' , , .
~ -28-.. . . . . .

. . .
. . .
' ' ' .; -.".,'. ' " ,: , ,. ' ' , ' ' ' , ' ' . ' ' ' . . .

j 10613698 ' :. ¦ ! .
. . _AMPJ,E ~0 When the procedures of Example 1 and F,xample 6 are repea~ed but ¦ using the appxopriate starting material~ in each case the following compounds of formula (II) are obtained. ::
X : .
C3(1~

. , R3 R4 :
` , ' ~ : ''' ' ~' ' .

X Rl R3 P~4 ~
. _ _ , . ..
- : ~ Cl 11- succinimido . Br H- maleimido Cl CH30- phthalimido - . -I Br CH30 succinimido 10 ¦ . . . Cl CH30- maleimido -Br H-- H 4-CH30C6H4CH2- ~ . :
Cl C~d30- H 2-BrC6H4CH2- .
~:: Cl CH30- H C6H5C~l2 Cl CH30- H 4-N02C6H4CH2 15 ¦ Cl H- H 4-ClC6~14CH2-Br C~130- H 3-CH3C61~4CH2-Br H-- phthaiimido . .~.
I Br H-- .H C6H5CH2- : ~
! Br H-- 2 6 4 2 `: :
20 ¦ Cl CH30- H ~ 2 6 4 2 ~ Br U-- 11 3-ClC6H4C1l2-,1 , , .
11 .. . ,. , . . ,~' .' ,.,. ~ -29- , , .::

I . . ':'. ': :
I . ll '... .

" , , ' ;: ' ' ., ' ',:' ~ ' " ':, ' , : . ., ' , . - . , . , .................. , , ~ . , ;:
- ~ . . , ~ , : . -' : ' . , ~ ' ", : , .' . :::, ~ . : . .
... . .. . . . . ..

_ ~61~698 ~

EXAMPLE 11 :~ :
When the procedures of Examples 2 and 7 are repeated but in each case employing the appropriate compound of Formula II selected from those provided in Example 10 and -the appropriate l-substituted piperazine as starting materials, the following compounds of Formula (IV) are obtained.

CH3 ~ ~ R R R (IV) N

R R
3 4 ..
Rl R2 3 R- -CH2CH=CH2 phthalimido H- -CH2CH=CHCH2CH3 succinimido -CH2CH=C(CH3)2 maleimido : 10 H- -COC6H5 H 3 6 5 2 3-furoyl H r 6 4 2 H- 3-thienylcarbonyl phthalimido CH30- 2-thienylcarbonyl H 2 6 4 2 . H- -COOCH3 H 4-ClC6H4CH2-CH30- -COOCH2CH3 H 3-cH3c6H4cH
CH30- -COOCH2CH(CH3)2 phthalimido : H- -coocH2cH(oH)cH3 H C6H5CH2-3 , -CcH21c(cH3)~2 succinimido . OH

OH
CH30- -COOCH2CHCH2CH3 maleimido bH

.. . . . . .
. :.. . ..
. . :. .
, ,, . , , ~ , . . ;
:: . :
, :. : ' :
.: ,. . ; :
, 1al6~698 ,. . .

EXAMPLE II~(Continued) R2 R3 R4 _ _ H- -COC6H5 phthalimido CH30- 2-thienylcarbonyl phthalimido CH30- 3-thienylcarbonyl H 2 N2C6H4CH2 H- -CH2CH=C(CH3~2 H 3-Clc6H4cH2~
CH30- CCH21C CH2 phthalimido H COOCH2CH CH2 succinimido H -COOCH3 maleimido "
: , ', ' '':
' .

, ' ;
~'' ''' ' ~ ~' , :, . , :":

,, "' ' ~',,",' ,'' . ~ " ,, ' ',",' '. ' ~ ' ''.,,., ' '': " ' - , , , . . . :"

..
- . : , . . .
, ~ , . . ~, .. . .

-`` 1(;~68698 EX~MPLE 12 Employing the catalytic hydrogenolysis procedure described in Example 3, but with the indicated start;ng material in each case selected from those provided in Example 11, the following compounds of Formula (I) are obtained.

CH3~ _R~2 N ~ ~ NH2 R~ 4-CH30c6H4cH2-CH30- 3-furoyl 2-BrC6H4CH2-CH3 2-thienylcarbonyl 4-N02C6H4cH2-H- -COOCH3 4-clc6H4cH2-H- ' -COOcH2cH(OH)cH3 C6H5CH2-: ~ ~ H- -coocH28HcH3 4-N02C6H4CH2-H
: 15 CH30- 3-thien~lcarbonyl 2 N02C6 4 2 H- -CH2CH-C(CH332 3-C1C6H4CH2 :

, .

~ . . . . . . . .. .
. . .
.. . . . . . .. .
,. , ~ ... .. . . .
,. . . :
. ,. ,- . . , ,., , ~. , . , ;., ~, :., : . , , :, . . . ... .

. : ' , ' , ',"' ' ' ' . ,- ' ' ,' , ' ' ~ . ': :: : ' ' . .' " . .: , ,:

369~3 , :

~ hen the appropriate compound of Formula (IV), selected from thoseprovided in Example ll, is hydrolyzed by the procedure of Example 8~ bUt employing an equivalent amount of the indicated acid and carrying out the 5 hydrolysis at the indicated temperature for the indicated time, the followin~ :
compounds of Formula (I) are similarly obtained. ., 3 ~ ~ 0 2 2 ~ ~ ~ N-R2 CH3 ~ ~R .

N (IV) (I) NH2 :
/ \ "~
R3 R4 . . Time R~ R2 R3 + R~ Acid TC Hours -:~ H-CH CH CH phthalimido 48% hydrobromic 50 l : :
H--CH2CH=CHCH2CH3 succinimido 96% sulfuric 0 6 CH30-CH2CH=C(CH3)2. maleimido 85% phosphoric 100 / 0.25 CH30--COOCH2CH(CH3)2 phthalimido37% hydrochloric. 20 2 CH30--CcH2lc(cH3)2 succinimido 48% hydrobromic H -:
3 21 2 3 chloric . 10 4 : 15 H COC~ 5 phthalim~do, 37% hydrochloric 20 2 ~:
CH30- 2-thienyl- phthalimido , 37% hydrochl~ric20~ 2 carbonyl :
H 3-thienyl- phthalimido ,37% hydrochloric 50 0.75 carbonyl CH30 -C008H2=CH2 phthalimido 37% hydrochloric 25 2 H3 ` .
H -COOCH3 maleimido 80% 9ulfuric 25 2 ~t ' ,'. `, ' ' ' " ... ' ' ' . ' ' ', . ' ,~ ~' " ' ' ', ' .. .. . . . . . . . . .

' ' '''', "~'' ''.'. ,'' '"., ,,',''," .''".","'. '' '.' ',,, ,' ' ;' ~;' ', : '' , 061~698 When the appropriate compound of Formula (IV), selected from those provided in Example 11 is employed in place of 2-~4-(2-furoyl)piperazin-1-yl]-~-phthalimido-6,i-dimethoxyquinazoline in the procedure of Example-9 under the indicated conditions, the following final products of Formula (I) are also obtained. Rl 3 ~ ~ ~ N 3 _R2 3 ~ ~ ~ -R

~ N ~ CH30 ~H2 ~IV) ~I) ::

- -34- : .
:' ' ~ :,, : . . .,. : . .. . . i .. . : .. , : :: ., ,., .. ,, . : , : . " . .

:, . , . : : , .. ,. . , , .: , .
:: ., : , . . , , . :
''' ' ' , :, . : . .. . . . . ..

~(~681i98 EXAMPLE 14 - (Cont'd) Time ~L_ R? R3 -~ R4 SolYent TC Hours H- -CH2CH-CHCH2CH3 succinimidoisoamyl alcohol100 1 .
H- -COC6H5- phthalimido ethanol 50 4 CH30- 2-thienyl- phthalimido n-butanol 0 48 carbonyl ' CH30- -CcH2cH~cH3)2 phthalimido DMF* 100 0.5 CH30- -COOCH2CtCH3)2 succinimido di~lyme~ 25 20 CH30- -COOCH2CHCH2CH3- maleimidoethanol20 24 . ~ :
H
CH30- -COOCH2C~ CH2 phthalimidodiglyme 20 18 ~:

H 3-thlenyl- phthalimidoisoamyl alcohol50 4 .-carbonyl : .
H -CH2CH=CH2 phthalimidO ethanol 20 18 2 2 succinimido DMF* 100 1 ~:
H -COOCH3 maleimido ethanol oo 48 *N,N-Dimethylformamide ~ .
~Diethyleneglycol dimethylether :.
~ ' .

..
.

, . - .. :- . . . , . - , . , . . ,, .. ... ,.. :. :.. - .,:, .:

EXAMPLE L5 _ , '' .
4-BenzoYlamino-2-chloro-6,?-dime~hoxyquinazoline . ' ' ' , .
In a 100 ml. three-necked, round bottomed flask fitting witll reflux condenser, thermometer and drying tube were placed 32 ml. oi~ dry tetr~lhydro-5 furan, 10 ml. of dry N,N-dimethylformamide, 6.48 g. ~0.025 mole) 294-llichloro-6,7-dimethoxyquinazoline [prepared by the procedure of Curd et al., J. Chem.
Soc., 1759 (1948)],3.03 g. (0.025 mole) of benzamide and 2.4 g. (0.051) mole) of 50% w/w sodium! hydride, the hydride being added last. The resultil~g mixture was heated at reflux for 24 hours, cooled to room temperature and fil,~ered, 10 washing with tetrahydrofuran, to obtain 6.0 g. (66~) of the sodium saLt of the title compound, M.P. 315 C.
Upon slurrying 1.0 g. of t~le sodium salt in 20 ml. of water, acidifying to p~l 3 4 with 2N hydrochloric acid, stirring for 15 minut!~s at ~ 20-25 C, filtering and drying overnight, 0.67 g. of the title compoulld was 15 obtained. ~I.P. 235-240 C. Upon recrystallization from isoamyl alcoh!~l, it ~elted t .6-23a~ c. h- mas~ spectrum ~ ~wea peak6 at Y/e 34 and ~44.

,1, 1 , ,.~' '. . ' ' ' ' ' . ' -36- ' ~
. . ~ . . '' ' ' ' ' '~
: -,, . .. , . , - . . . . : . . ,. .. . . ,, ,, - . . . , , :. .
.. - .:. ,: :: . : ., .. , .. , ... ., ... :;", , .,, ,, ~ . :, "," ,, . ~ - , , , . , : ,, . , . . .: ., .. . ~ .: .
", : : ' ': ' ' ' . ' , - ' ,:, ~ , : : ' , . . :: . : ~ ~ , :
. : . , . . . , ,. , . , .: : : , : , .....

061~i698 EXI~'LE l6 4-l~cetylamino-2-cllloro-6,7-diillothoxyquina~ollne In a 100 ml. reaction vessel were placed, 6.48 g. ~0.025 mole) 1 2~4-dichloro-6,7-dimethoxyquinazoline, 1~5 g. (0.025 mole) acetamide, 32 ml. ~;
5 ¦ of dry N,N-dimethylformamide and 2.4 g. (0.050 mole) of 50~ sodium hydride.
Upon warming to 40 C., an exothermic reaction commenccd and the temperature rapidly increased to 120D C. with considerable foaming. During this exothermi period the reaction mixture turned purple, then red. The mixture was cooled to 90 C. and maintained at this temperature for two hours. The mixture was 10 ! then cooled to room temperature, poured into 150 ml. of water, washed with j two l00 ml. portions of cTlloroform and ~hc aqueous phase adj usted to pH 2 ~; ;
¦ by addition of concentrated hydrochloric acid. 'rhe precipitated product was ¦ coilected by filtration and dried to obtain an 86~ yield of the title compound,~ -li M.P. 275 C. Only one spot was obtained on thin-layer chromatography on 151i silica gel, eluting with 95:5 ethyl acetate/diethylamine. The mass spectrum il showed a molecular ion at M/e 281.

I
- ' , '. ~ -3i- j .,. . ' ' . . ' ,,'' . , . ":.
. . ' ' ' ' ,~ . ~ ' ,,, ~..... . . . . . .. . .. . . .
... . . . . . . . . . . .. . .. . ..
:: ., ,.. -.. ,' , : . . . . :' :..... : , ' ~: ,, , ,- , . . . . . . .
. : ,. . . .: : ' ,, ' .

06t369~

E ~IPLE 17 . ' I . , , . '~ .
. I ~hen the procedures of Examples 15 and l6 are repeated but with an equimolar amount of the appropri.ate alkylamide or arylamide in place of.the :~
amides employed therein, and in those cases where Rl is methoxy, employing 5I an equimolar amount of 2,4-dichloro-6,7,8-trimethoxyquinazoline, obtained bythe procedure of ~.S. 3,669,968, in place of 2,4-dichloro-6,7-dimethoxy-~ui=azoIine, ~he foIIo~ing compoonds are prep~re~. ¦

11, ' .

,. ........ , .. " ,., .. , , ,.. .... ..... .... ,.... . .. ~; ,, ..... ... , .. ~` .,. .- . . . .
.. .. , .. " . ... .... ... , .. ,. . .. , . . .. . ., ~, ...... ., . . . . , ; , , . ; . . .
.,. ,, .......... , . .... " . ", .,.. , .. , , .,. .,... ., ., ... - ~. .. . . . . .. .. .. ...
..... ., ., . ,.. ,, . - .......... . . ,.,", . ,, ;....... ., :.. .: . .
.... ., .......... ,. ..... , . .. , . ,, . .... , , ,,., . . . .... , ;. . ... .
' .", ' , , ,. . . : , . , ! , . ~, ,' ; ., ' ., . , , ' ,. , , , ~,;, , ', '. ," ' ' , ;, .; .. , ':

~ ; 106~i6~8 ~ I ~

EXAPfPLE 17 (Con' t) ' .- . .
. : , -', , ~1 . .
C~I~C~
. ............ , , . ','~., . ." , .
., ~ ~ , .

: 1 4 1 . 4 . H- HC0- G1130- HC0-l C 3CH2C0 3 C113C0 .
:~ . H CH3C~12CH2cO- 3 ( 3)2 . I .
5 1 ( 3)2CHC~2C0C1130 - C113(C~12)3C0 . H- 4-ClC6H4C- 3 3 6 4C
H- 2-BrC6H4C0- CH30- 4-N02C6H4cO- ¦ ¦
H- 3-N02C61~4CO- CH30 3 ClC6 4 H- C~3Co_ CH30 3 ': ' I i' "
.
. Il '. 1" " ., .

:1. 1 , ,, , ~:

, i ' ~ , ' ' ' ' . . :
.

:

. 1~6i~698 : .,` . . ':
EXI~LE 18 4-Ethoxyc~rbonylamino-2-chloro-6,7-dimethoxyquinazoline 2,4-dichloro-6,7-dimethoxyquinazoline (6.48 g., 0.025 mole), 32 ml.
tetrahydrofuran, ethylcarbamate t2.23 g., 0.025 mole) and 50% sodium hydride (2.4 g~, O.OS0 mole) was placed in a 100 ml. reaction flask fitted with therm-ometer reflux condenser and drying tube. The reaction mixture was refluxed for two hours after which 70 ml. of methanol was slowly added, the resulting mixture heated to 60 C. and filtered while hot. The filtrate was concentrate ¦ to a thick slurr!y, the solid collected by filtration washed with 5 ml.
10¦ chloroform to obtain 5.4 g. (70%) of t',^~e title compound. A samp~e ~pon recrystallization from a mixture of tetr~hydrofuran and hexane (2:3) melted at 212 C.
., I

Anal- Calc~d for C13H14N3O4Cl (percent): C, 50.09; H, 4.53; N, 13.4 ~o~nd: C, 49.95; 1{, 4.46; N, 13.54 ''"~

~40-' ~ ~

I , ' '~
. ~ ''` ' '' I

:. , . ., ', - ' . . ', . : . ,:
. . :, . , . , , :.

:- ~ 1068698 ~ ~
EXAMPL~ 19 . .
4-PhenoxYcarbonylamino~2-chloro-6,7,8-trin,ethoxyquinazoline In a 500 ml. flask i9 pl~ced 25.S g. (0.10 mole) 2,4-dichloro-6,7,8-trimethoxyquinazoline prepared as described in U.S. 3,669,968, 13.7 g.
S (0.10 mole) phenylcarbamate (Aldrich Chemical Co.), 130 ml. tetrahydrofuran and 9.6 ~. (0.20 mole) of a 50~ dispersion of sodium hydride. The resulting mixture is refluxed for 4 hours~ cooled to room temperatare, 250 ml. of methanol is added and the mixture warmed to 60 C. and filtered. The filtrate is concentrated,to a thick slurry, the solid collected by filtration and washed with chloroform to obtain the title compound.
When 2,4-dibromo-6,7,8-trimethoxyquinazoline is employed in the above procedure in place of 2,4-dichloro-6,7,8-dimethoxyquinazoline, 4-phenoxy -carbonylamino-2-bromo-6,7,8-trimethoxyquinaæoline is similarly obtained.

. ~ ' 111 . ' .' ' I ' ,..... .

1- ' ' , . ....
I ' , t ' -41- ' '' ' :

.. ,~, ~ ' ' ' . , ' ~ , , , , 1' ,1, , ~ .
. . ... ~ ' - . . , ', .

.
, . . :
. .
. : , , ': :
': . . , . ', , . '. . ; ' - t ~.~6g69~ I
~ I ~ ~
When the procedures of Examples 18 and 19 are repeated~ but e~ploying the appropriate starting materials in each case~ the following . compounds are likewise obtained.
. .
Rl CH30 ~ N ~_ Cl . C~30 ~ ~
: ' NHR4 Il ' , . ,~ ,, -., 11 ` ' ,, ' ' . ';.':':
Rl R4 1 4 1 ~ ~
.. . ._._ ...
~1 ~130C0- C~130_ C113CIl20C0-¦l H (CH3)3cOcO- CH30- (CH3j2 ll H C6H50C0- 3 3t 2)3 : ¦I H 4-Clc6H40co- CH30- 4-BrC6H40co-10 ¦¦ H 2-BrC6H40C0- CH30- 3-CH3C6H40C0-!I H 3-CH30C6~40Co-CH30- 4-N02C6H40Co-¦~ ~ H 4 ~2C6~4c CH30- C6H5C~l20co- , . : ~:
¦¦ H 4-ClC6~14c~20cO- CH30- 4-BrC6~l4cH20co-1¦ H 2-CH3C6H4cH2oco- CH30- 2-C~130C6H4CH20C0~ ~ . :
15 ¦ :i 2-NOzC6114Cii2oCo~ Cil30- 4 ClC6H4C

! . . ' . . :'.:' ' . ' ., . :', ':
' . -42-. . , .
. . '~ . ' .

' . . ' ", ' ' '' ' ' ' '' .', ' ," ,''' '.,', ", "'.;"' "" "' " "`,''''' '~ , ''~ ' :. ' .1 ^ ~0686~8 - , ~

_XA~PL~ 21 2 [4-(2-furoyl)piperazirl-l-yl]-4-amino-6~7-_ _ dimeLlloxyquin?zo].ine __ To a 50 ml. flask fitted with stirrer, reflux condenser and dryin~ tube was added 160 mg. (0.66 mmole) 4-benzoylamino-2-chloro-6,7-dimethoxyquinazoline prepared by the procedure of Examples 15, 244.2 mg.
(1.32 mmole) 1-(2-furoyl)piperazine and 4 ml. of isoamyl alcohol. The ~esulting mixture was heated at 100 C. for ~ hours then cooled to room - lO ~temperature. The precipitated solid was collected by filtration and dried, to obtain 60 mg. of crude product. It was identified as 2-[4-(2-furoyl)- ¦ -piperazin-l-yl]-~ amino-6~7-dimethoxyqulnazoline by silica gel thin-layer chromatography (etllylacetatc/diethylamine 90:10). The crude material was purified on a O.5 inch x 9 inch column of silica gel, eluting with benzene/
acetone/formic acid/water (100:100:20:5, by volume) to provide 35 mg., M.P. 275 C. -~hen the above procedure is repeated but employing the indicated solvent in place of isoamyl alcohol and carrying out the reaction ¦ employing the tabulated temperatyre and time in each case, the title compound ¦ is obtained in like manner.
I . : .
I . - ' '' .
Solvent Reaction Reaction Temperature, C. Time, Hours _ _ . .__ _ 2-Butanol 50 50 I -2-Methoxyethanol 80 18 1, 2-Methyl-2-pentanol 130- 2 Diethyleneglycol 200 0.25 , . . . .
,., ,- ' - . .
43 , -.~ / .' , : ~ - '-, :- ' ' : ': -- ,:

- ~ ,.,,",.,",~ -' ~ , :, ' ' :: " ' , ~
. ~

~- ~ 68~9~ ~

EX~ E 22 2-[4-(2-~uroyl)pi~erazin-1-yl]-4-amino-6,7-dimct!loxyquina~oline _ _ - 4-Ethoxycarbonylamino-2-chloro-6,7-dimethoxyquinazoline, (2.0 g., 0.0064 mole) and 23 ml. of isoamyl alcohol were combined in a reaction flask. A solueion of 1-(2-furoyl)piperazine (2.54 g., 0.014 mole) in 18 ml. of isoamyl alcohol was added and the mixture heated at 130 C.
for 4 hours. The precipitated solids were collected on a filter funnel, ~ashed with isoamyl alcohol then stirred with 100 ml. of 10% aqueous sodium hYdroxide~ ~n equal volume of chlorofo-;m was added and the mixture stirred for 15 minutes. The organic layer was separated, concentrated to about 25 ml. and 50 ml. of tetrahydrofuran added. The solids were collected by filtration then ~urther purified by chromatography on a silica gel column 11 x 18 inches) eluting first with ethylacetate, then with methanol. The ¦ ~
151 fractions containing the title compound were com~ined and evaporated to ¦ - ;
I ! dryness. The residue was taken up in 10 ml. of chloroform, hexane added to ~ ;
the cloud point, stirred 15 minutes and the crystals collected by filtration, ¦ -! M-P- 265 C., yield 900 mg. (37%).
~¦ When the above reaction is repeated at 80 C. for 18 hours, the 20¦ resu~s are substantially unchanged. , ' . , ~

I ~ ' ~
''' I, . ,' . ':' ' ~,1, ~ '" ' ' ' I '''.. '':
-. ' ~ . ' ' . '' ~''~''`''", .,, i, ' , , ,. ~
'.

~ 4_ ;

~061~98 EX~MrLE 23 2-(4-~enzoyl-1-piperazlnyl)-4-amino-¦ 6,7-dimethoxyquinazoline hydrocllloride 4-Acetylamino-2-chloro-6,7-dimethoxyquinazoline (28.2 g., o.lb mole), l-benzoylpiperazine (38.0 g.) 0.20 mole) and 750 ml. o~ isoamyl alcohol are combined. The resulting mixture is refluxed for three hours then cooled to room temperature. The precipitated product was filtered, washed with ¦ ethYlacetate~ then with ether and air dried to obtain the title compound.

¦ I EX~MPLE 24 10 ¦ 2-[4-(2-Hydroxy-2-methylprop-l~yloxycarbonyl)-piperazin-l-yll-4-am-ino-6~7~8-trime~hoxyquinazolinc 4-Phenoxycarbonylamino-2-chloro-6,7,8-trimethoxyquinazoline ¦ (19.5 g., 0.05 mole), 1-(2-hydroxy-2-methylprop-1-yloxycarbonyl)piperazine I ¦ (20.2 g., 0.10 mole) and 500 ml. of diethyleneglycol dimethylether are heated at 125 C. for two hours. The reaction mixture is concentrated . in vacuo to about 200 ml. and an equal volume of ethyl ether is added. The I ~ precipitated hydrachloride salt is filtered, washed with ether then stirred with 200 ml. of saturated aqueous sodium carbonate solution. ~he liberated I --base is extracted with 3 x 200 ml. portions of chloroform and the extracts ~20~ concentrated to about 150 ml. Diisopropyl ether, about 100 ml., is added and the mixture set aside overnight, then filtered $o yield the crystalline ¦ title compound. ;
When the above procedure is repeated with an equimolar amount of 4-phenoxycarbonylamino-2-bromo-6,7,8 tximethoxyquinazoline in place of the corresponding 2-chloro compound and the reaction mixture is main~ained at 50 C. for 40 hours, at 80 C. for 15 hour's, or at 200 C. in a high pressure reactor for 25 minutes the title compound is obtaincd in the same manner.

': , ' . ~
- -45- , .
. I .
. .''~ .
-.' ".' ' . ' ' ' , , , " ' ' ' ,",, . '' ' ' ', ~' ' ' ' " ' ' . I ., ' '. ~ , '. ' , ., ~, ' . ' ' ' , . ' .
' ~ ,," " .

, 368~.;98 Ex~ E 25 , When ~he compounds obtained in E~amples 17 and 20 are xeactedwith the appropriately ~ubstituted pipera~ines of fo~mula tIII) by the pro-cedures of E.~amples 21 through 24, the following compounds of formula (I) 5¦~ ~re ~ rly obCl m ed.

¦ 3 ~ , N~ Cl ~ CN30 ~

¦ C~30 NHR4 12 CH30 NH
I , , 1 (III) (I) I . , ' ' .

l 4 ~2 . H~ ~CO- . -CH2CH=CH2 H- CH3CH2CO- CH2CtCH3)=CH2 1 . H- CH3CH2CH2CO- -CU2C(CH3)=CHCH3 lO1 H- (C113)2CHCH2CO- -COC6H5 ! H- 4-ClC6114CO- 2-furoyl jl H- 6 4 3-furoyl I¦ ~_ 3-N02C6114CO- 2-thienylcarbonyl l H- 4-CH30C6H4co- 3-~hi~nylcarbonyl 15 1 C}130- ~CO- -COOcl13 CH30- C1l3CO- -COOC112C113 C~130- (CH3)2CHCO- -C00~12(CH2)2CH3 l C~130- C~13~C112)~C- , -coocll2c~l=cll2 1 1 CH30- 4-C11 C H CO- -Cooc~2ctcH3)=cH2 3 4 2C6H~co -COOC1t2CH=C11CH3 3- 3 ClC6114CO- . -C00~12C(0;-1)(C1~3~2 CH30- C6~15C- -COOC312C11(OH)C~13 . ~1- C1130CO- ~Coocll2cllto~l)cl~3 H- CF3CO- 2-fur~yl /
.~ -46- ' .. . . . . ..
. , . . . ', .' ' ' . ~ ' ,. . :

...
.
, 06~36~8 , l EXl~l:PLE 2~S (Continu~d) . ~ I
. . ' ' "' ' . , . : , Rl R4 R2 ._ ..
, ~
H- ( 3)2COCO -cOOC~l2c(OH) (CH3~2 H- C6H5C- -COOCH2c(cil3)=cH2 l H- 4-clc6H4()co- 2CH CH2 5 1 H- 2-BrC6H40Co- -COOCH2CH (CH3) 2 ¦ .! H- 4-No2c6H4oco- -COOCH (CH3) 2 I H- 4 ClC6H4C~120C -COOCH3 . H- 2-cH3c6~l4cll2oco- 2-thienylcarbonyl . H- 2 6 4 2 2-f uroyl C~30- CH3CH20C- 3-furoyl . ~:
¦ CH30-(CH3)2C110CO- 2-furoyl , .
CH 0-C113~ Ii2l 30CO- C 2 2 CH30- 4-BrC6H40co- 2 ( 3) CH2 . : :
~: CH30- 3-C~13C6HbC- CH2C(CH3)=CH2 C1130- 4-N02C6~140CO- 6 5 3 C6H5cll2oco -COOCH2CII-CE12 :~
CH30- 4-BrC6H4cH20co- -COOCH2C(CH3)=CH
3 3 6 4CH20CO -COOCH3 ~ ::
C1130- 4-clc6H4cH2oco- -COOCH2CH3~ ~ :
20 ~11 CH30-- OE3CO -COCcl~2c~cii3~-~i2 , : , .

l ~ .
;:'~ i 1 - , ~ .
, . ' . . ~

I , -47~ ' ' -- :
;: ,.' ~' . . . , .
.~1 , .. ' . ' .
: :-, - .. :. - ~: :, , - - ,, . :. . . ~ ~ ~ . .

: . , . ; , : , . " , , ~ ' ' ' '~
. ' ., : , ': : - . : . , ' , : ' - ; ' ': : :" ~ ' ' ,, , : , . . .
: '.' , , : ~ . , ., , - ~ . .
; :

Claims (14)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A process for preparing a compound having the formula:
...I
or a hydrochloride or hydrobromide acid addition salt thereof, which comprises reacting one mole of a first reactant having the formula:
...II

with from one to two moles of a second reactant having the formula:
...III
in a reaction-inert organic solvent at a temperature from 50°
to 200°C. wherein R1 is hydrogen or methoxy, R2 is alkenyl hav-ing from three to five carbon atoms, benzoyl, furoyl, thienyl-carbonyl, alkoxycarbonyl having from two to five carbon atoms, alkenyloxycarbonyl having four or five carbon atoms or (2-hydr-oxyalkoxy)carbonyl having four or five carbon atoms; X is chlorine or bromine; R3 is hydrogen and R4 is -CH2C6H4R5, -COOCH2C6H4R5, -COR6, -COCF3, -CHO or COOR6, or R3 and R4 together with the nitrogen atom to which they are attached form a cyclic imido group; R5 is hydrogen, chlorine, bromine, methyl, methoxy or nitro; and R6 is alkyl having from one to four carbon atoms or -C6H4R5.
2. A process according to claim 1, wherein, in the com-pound of Formula II, R3 and R4 together with the nitrogen atom to which they are attached form a phthalimido, maleimido or succinimido group.
3. A process according to claim 1, wherein the reaction is carried out at a temperature from 80°C. to 130°C.
4. A process according to claim 1, wherein, when R2 is benzoyl, furoyl, thienylcarbonyl, alkoxycarbonyl having from two to five carbon atoms or (2-hydroxyalkoxy)-carbonyl having four or five carbon atoms R3 is hydrogen and R4 is -CH2C6H4R5, equi-molar amounts of the reactants of Formulae (II) and (III) are re-acted to form an intermediate having the formula:
...IV
and the said intermediate is further reacted by catalytic hydro-genolysis to form the desired final product of Formula (I).
5. A process according to claim 4, wherein the said cata-lytic hydrogenolysis is conducted in the presence of a palladium catalyst.
6, A process according to claim 1, wherein, when R3 and R4 together with the nitrogen atom to which they are attached form a cyclic imido group, equimolar amounts of the reactants of Formulae (II) and (III) are reacted to form an intermediate of the formula:
...IV
wherein R1, R2, R3 and R4 are as defined in claim 1, and the said intermediate is further reacted at a temperature from 0° to 100°C.to form the final product of Formula (I) either:
a. by hydrolysis, or b. by reaction with an equimolar amount of hydrazine in the presence of a reaction inert organic solvent.
7. A process according to claim 6, wherein the cyclic imido group is a phthalimido, maleimido or succinimido group.
8. A process according to claim 6, wherein the hydrolysis of step a. is carried out in the presence of hydrochloric, hydro-bromic, sulfuric or phosphoric acid.
9. A process according to claim 6, wherein the further re-action of the intermediate is conducted at a temperature from 20°
to 50°C.
10. A process according to claim 1, wherein, when R3 is hydrogen and R4 is -COOCH2C6H4R5, -COR6, -COCF3, -CHO or -COOR6, one mole of the said first reactant and two moles of the said second reactant are reacted to directly provide the final product of Formula (I).
11. A process according to claim 1, wherein R1 is hydrogen and R2 is 2-furoyl.
12. A process according to claim 1, wherein R1 is methoxy and R2 is 2-methyl-2-hydroxyprop-1-yloxycarbonyl.
13. A process according to claim 1, wherein R1 is methoxy and R2 is 2-methylprop-2-enyloxycarbonyl.
14. A process according to claim 1, wherein X is chlorine.
CA278,728A 1976-06-15 1977-05-18 Process for preparing substituted aminoquinazoline derivatives and intermediates therefor Expired CA1068698A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69620176A 1976-06-15 1976-06-15

Publications (1)

Publication Number Publication Date
CA1068698A true CA1068698A (en) 1979-12-25

Family

ID=24796111

Family Applications (1)

Application Number Title Priority Date Filing Date
CA278,728A Expired CA1068698A (en) 1976-06-15 1977-05-18 Process for preparing substituted aminoquinazoline derivatives and intermediates therefor

Country Status (34)

Country Link
JP (1) JPS52153985A (en)
AR (1) AR218251A1 (en)
AT (1) AT356115B (en)
BE (1) BE855656A (en)
BG (3) BG35594A3 (en)
CA (1) CA1068698A (en)
CH (3) CH638203A5 (en)
CS (1) CS202069B2 (en)
DD (1) DD131021A5 (en)
DE (1) DE2725019A1 (en)
DK (1) DK146625C (en)
EG (1) EG12922A (en)
ES (1) ES459364A1 (en)
FI (1) FI66853C (en)
FR (1) FR2355015A1 (en)
GB (1) GB1548856A (en)
GR (1) GR72288B (en)
HK (1) HK31481A (en)
HU (1) HU177883B (en)
IE (1) IE45423B1 (en)
IL (1) IL52167A (en)
LU (1) LU77530A1 (en)
MY (1) MY8100270A (en)
NL (1) NL172543C (en)
NO (1) NO147838C (en)
NZ (1) NZ184168A (en)
PH (1) PH22196A (en)
PL (3) PL113012B1 (en)
PT (1) PT66617B (en)
RO (3) RO77308A (en)
SE (2) SE435380B (en)
SU (2) SU1033002A3 (en)
YU (1) YU40164B (en)
ZA (1) ZA773014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346675A1 (en) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 1- (4-AMINO-6,7-DIALKOXY-CHINAZOLINYL) -4- CYCLOHEXENYL DERIVATIVES OF PIPERAZINE AND HOMOPIPERAZINE, METHODS FOR THE PRODUCTION THEREOF, AND THEIR USE, AND ITS RELATED PRODUCTS
AT384218B (en) * 1985-12-04 1987-10-12 Gerot Pharmazeutika METHOD FOR PRODUCING NEW CHINAZOLINE DERIVATIVES
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5679683A (en) * 1994-01-25 1997-10-21 Warner-Lambert Company Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3669968A (en) 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
JPS536156B2 (en) * 1972-10-30 1978-03-04
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
JPS50126682A (en) * 1974-03-25 1975-10-04

Also Published As

Publication number Publication date
SU946402A3 (en) 1982-07-23
DK240877A (en) 1977-12-16
ZA773014B (en) 1978-04-26
EG12922A (en) 1980-03-31
BG35594A3 (en) 1984-05-15
NO771919L (en) 1977-12-16
SE435380B (en) 1984-09-24
DK146625B (en) 1983-11-21
FI66853B (en) 1984-08-31
NL172543B (en) 1983-04-18
RO77308A (en) 1981-08-17
FI66853C (en) 1984-12-10
NL172543C (en) 1983-09-16
AU2558377A (en) 1978-09-07
HU177883B (en) 1982-01-28
DE2725019A1 (en) 1977-12-22
PT66617B (en) 1978-10-27
SU1033002A3 (en) 1983-07-30
FI771741A (en) 1977-12-16
PT66617A (en) 1977-06-01
PH22196A (en) 1988-06-28
SE7705745L (en) 1977-12-16
YU132677A (en) 1982-08-31
FR2355015A1 (en) 1978-01-13
BE855656A (en) 1977-12-14
PL105558B1 (en) 1979-10-31
GR72288B (en) 1983-10-17
FR2355015B1 (en) 1981-07-24
PL111221B1 (en) 1980-08-30
CS202069B2 (en) 1980-12-31
DK146625C (en) 1984-06-04
IL52167A (en) 1981-01-30
NO147838B (en) 1983-03-14
NO147838C (en) 1983-06-22
DD131021A5 (en) 1978-05-24
CH638203A5 (en) 1983-09-15
ATA386977A (en) 1979-09-15
JPS5543465B2 (en) 1980-11-06
SE8107554L (en) 1981-12-16
LU77530A1 (en) 1979-03-26
PL113012B1 (en) 1980-11-29
PL198874A1 (en) 1978-04-10
BG35747A3 (en) 1984-06-15
AR218251A1 (en) 1980-05-30
ES459364A1 (en) 1978-03-16
CH638516A5 (en) 1983-09-30
NZ184168A (en) 1979-08-31
BG35748A3 (en) 1984-06-15
JPS52153985A (en) 1977-12-21
SE450120B (en) 1987-06-09
GB1548856A (en) 1979-07-18
IE45423L (en) 1977-12-15
AT356115B (en) 1980-04-10
RO73050A (en) 1981-08-30
IL52167A0 (en) 1977-07-31
RO77330A (en) 1981-06-22
IE45423B1 (en) 1982-08-25
CH638517A5 (en) 1983-09-30
HK31481A (en) 1981-07-10
MY8100270A (en) 1981-12-31
NL7705939A (en) 1977-12-19
YU40164B (en) 1985-08-31

Similar Documents

Publication Publication Date Title
CA1175432A (en) N-oxacyclyl-alkylpiperidine derivatives, process for their preparation, pharmaceutical products containing them, and their use
EP0237781A2 (en) Phenyl and heterocyclic tetrahydropyridyl and piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
CA1068698A (en) Process for preparing substituted aminoquinazoline derivatives and intermediates therefor
US4314943A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4377576A (en) 5-(Heterocyclic amino-propionyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones
CA1211445A (en) Isoquinoline derivatives, a process for their preparation, pharmaceutical formulations based on these compounds and the use thereof
US4507478A (en) 2-Mercaptopyrimidohexahydroquinolines and related compounds
EP0117345B1 (en) Aminopyrimidinones as histamine h2-antagonists
US4705787A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US4575553A (en) Antitumor m-AMSA analog
KR900001420B1 (en) Process for the production of 4-amino -6,7- dimethoxy-2-(4-(furo-2-yl)-p (perazin-1yl) -qinazoline and physiologically compatible salts thereof
EP0134096B1 (en) Aminopyrimidinone derivatives as histamine h2-antagonists
RU1838309C (en) Method of synthesis of quinazoline derivatives or their pharmaceutically acceptable acid-additive salts
SU640661A3 (en) Method of obtaining arylalkylamines or salts thereof
Ciller et al. Synthesis of Heterocyclic Compounds, XXXVIII. Five‐membered Heterocycles by Cyclization of 3‐Benzoyl‐4‐oxobutanenitriles
SU999967A3 (en) Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts
US4202977A (en) S-Triazolo [1,5-a] pyridine derivatives
US3767679A (en) 3-substituted chromones
JPS6317828B2 (en)
EP0199485B1 (en) Intermediates and process
KR810000293B1 (en) Process for preparing substituted amino quinazoline derivatives
US4495352A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
CA1092117A (en) Method for the production of 6,7-dimethoxy-4-amino-2- ¬4-(2-furoyl)-1-piperazinyl| quinazoline having an antihypertensive effect
Fuentes et al. Synthesis of heterocyclic compounds. XXIV. Synthesis of pyridines from β‐substituted α‐phenylacrylonitriles
Schönafinger et al. Synthesis of 7, 8, 9, 10‐tetrahydropyrido [3′, 4′: 4, 5] pyrrolo [2, 3‐c] quinolines